Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical practice
Journal of Alzheimer’s Disease · 2026-06 · 111 (3) · 979-984
DOI: 10.1177/13872877261438522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 06.04.2026. Verfasst von José Manuel Alcalá Ramírez Del Puerto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoprotein E4, Apolipoproteins E. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
The apolipoprotein E ε4 allele ( APOE ε4) is associated with higher incidence of amyloid-related imaging abnormalities in patients with Alzheimer's disease undergoing anti-amyloid therapy, underscoring the importance of allele status testing. In this study, plasma ApoE4 levels were measured in 70 participants using Lumipulse ® G Pan-ApoE and ApoE4 assays and compared with traditional genotyping. ApoE4 concentrations and ratio ApoE4/Pan-ApoE differed significantly across non-ε4, ε3/ε4, and ε4/ε4 groups. No correlation was observed with age, sex, creatinine levels, or AD cerebrospinal fluid biomarkers. Diagnostic performance was excellent, indicating that proteotyping of ApoE can accurately classify the main APOE haplotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.
- Department of Clinical Analysis, Institute of Laboratory, Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain.
ORCID-Profile: Jordi A Matías-Guiu
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Alcalá Ramírez Del Puerto, J. M., Ortega-Madueño, I., Gil-Moreno, M. J., Abizanda-Saro, P., Palacios-Sarmiento, M., Millán-Guirado, R., Cruz-Cárdenas, M., & Matías-Guiu, J. A. (2026). Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical practice. Journal of Alzheimer’s Disease, 111(3), 979-984. https://doi.org/10.1177/13872877261438522
Vancouver
Alcalá Ramírez Del Puerto JM, Ortega-Madueño I, Gil-Moreno MJ, Abizanda-Saro P, Palacios-Sarmiento M, Millán-Guirado R, et al. Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical practice. Journal of Alzheimer’s Disease. 2026;111(3):979-984. doi:10.1177/13872877261438522
BibTeX
@article{AlcalRamrezDelPuerto2026,
author = {Alcalá Ramírez Del Puerto, José Manuel and Ortega-Madueño, Isabel and Gil-Moreno, María José and Abizanda-Saro, Pablo and Palacios-Sarmiento, Marta and Millán-Guirado, Rafael and Cruz-Cárdenas, María and Matías-Guiu, Jordi A},
title = {Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical practice},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
volume = {111},
number = {3},
pages = {979--984},
doi = {10.1177/13872877261438522}
}
EUVIMED